Clinical trials
Phase 1/2 Triple Negative Breast Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 2 |
| Abbisko Therapeutics Co, Ltd | 1 |
| Fujian Cancer Hospital | 1 |
| Henan Cancer Hospital | 1 |
| Henrik Ditzel | 1 |
| Huihua Xiong | 1 |
| Innolake Biopharm | 1 |
| Institut Bergonié | 1 |
| Queen Mary University of London | 1 |
| Taizhou Hanzhong biomedical co. LTD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Sarcoma | 2 |
| Stomach Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Transitional Cell | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.